SEC Form D private-offering filing

Ascribe Bioscience Inc.

Name: Ascribe Bioscience Inc. - new SEC Form D private-offering filing, Ithaca, NY
Published: 2025-10-15

A new SEC Form D private-offering notice from Ithaca, NY, a $15,272,656 filer-stated offering target in Biotech. The source filing is one click away.

Ascribe Bioscience Inc. site↗ Verified via SEC Form D

Develops natural crop protection biofungicides derived from soil microbiome molecules, including its flagship product Phytalix.

Filed 2025-10-15Filed to raise $15,272,656First money in 2025-10-08Raised so far $15,019,027HQ (as filed) Ithaca, NYSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified ascribebio.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.